Drug Trial Radar · NCT01016834
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
246
Actual
Start
Nov 30, 2009
Primary completion
Apr 30, 2010
Study completion Apr 30, 2010
Sponsor
- Lead sponsor
- Zogenix, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Synteract, Inc.
- First posted
- Nov 20, 2009
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.
Conditions
- Migraine
Interventions
Sumavel DoseProDevice
Needle free delivery system containing 0.5 mL of solution of 6 mg sumatriptan, subcutaneous administration
SumatriptanDrug
subcutaneous injection, 6 mg, per migraine attack, no more than two administrations within a 24 hr period
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Treatment Satisfaction at the End of the TreatmentTime frame: At the end of the treatment (after 4 migraines or 60 days, whichever came first)
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama Hospital, Dept. of Neurology
Birmingham, Alabama
Arizona Research Center
Phoenix, Arizona
C. Phillip O'Carroll, MD, Inc
Newport Beach, California
California Medical Clinic for Headache
Santa Monica, California
Alpine Clinical Research
Boulder, Colorado
University Clinical Research Inc.
Pembroke Pines, Florida
Comprehensive Neuroscience Inc
St. Petersburg, Florida
Comprehensive Neurosciences Inc
Atlanta, Georgia
Neurology Specialists of Decatur
Decatur, Georgia
Diamond Headache Clinic
Chicago, Illinois
Michigan Head, Pain, & Neurological Institute
Ann Arbor, Michigan
Clinvest/A Division of Banyan Group, Inc
Springfield, Missouri
Mercy Health Research
St Louis, Missouri
Meridian Clinical Research
Omaha, Nebraska
Regional Clinical Research Inc
Endwell, New York
Headache Wellness Center
Greensboro, North Carolina
Cleveland Clinic: Neurological Center for Pain
Cleveland, Ohio
Jefferson Headache Center
Philadelphia, Pennsylvania
Neurological Medicine
Clarksville, Tennessee
Nashville Neuroscience Group
Nashville, Tennessee
Swedish Pain and Headache Center
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.